
Journal Menu
► ▼ Journal Menu-
- JPM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
26 November 2024
Journal of Personalized Medicine | Collection of Title Stories from the First Half of 2024

Explore this exciting collection of title stories in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) from the first half of 2024. From cutting-edge research on breast cancer and respiratory diseases to innovative approaches in managing congenital heart disease and sepsis, these studies offer valuable insights and new perspectives for scholars and practitioners alike:
1. “Low CDKN1B Expression Associated with Reduced CD8+ T Lymphocytes Predicts Poor Outcome in Breast Cancer in a Machine Learning Analysis”
by Hyung-Suk Kim, Yung-Kyun Noh, Kyueng-Whan Min and Dong-Hoon Kim
J. Pers. Med. 2024, 14(1), 30; https://doi.org/10.3390/jpm14010030
Available online: https://www.mdpi.com/2075-4426/14/1/30
2. “Adult Congenital Heart Disease in the Emergency Department”
by Rachel A. Lindor, Kim Heller, Nicole R. Hodgson, Patrick Kishi, Jessica Monas, Douglas Rappaport, Aaron Thomas, Andrej Urumov, Laura E. Walker and David S. Majdalany
J. Pers. Med. 2024, 14(1), 66; https://doi.org/10.3390/jpm14010066
Available online: https://www.mdpi.com/2075-4426/14/1/66
3. “Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches”
by Natalie Fuchs, Longfei Zhang, Laura Calvo-Barreiro, Katarzyna Kuncewicz and Moustafa Gabr
J. Pers. Med. 2024, 14(1), 68; https://doi.org/10.3390/jpm14010068
Available online: https://www.mdpi.com/2075-4426/14/1/68
4. “The Relationship between Fine Particle Matter (PM2.5) Exposure and Upper Respiratory Tract Diseases”
by Łukasz Zaręba, Katarzyna Piszczatowska, Karolina Dżaman, Karolina Soroczynska, Parham Motamedi, Mirosław J. Szczepański and Nils Ludwig
J. Pers. Med. 2024, 14(1), 98; https://doi.org/10.3390/jpm14010098
Available online: https://www.mdpi.com/2075-4426/14/1/98
5. “Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making”
by Fernando Ramasco, Rosa Méndez, Alejandro Suarez de la Rica, Rafael González de Castro and Emilio Maseda
J. Pers. Med. 2024, 14(1), 106; https://doi.org/10.3390/jpm14010106
Available online: https://www.mdpi.com/2075-4426/14/1/106
6. “Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care”
by William Evans, Eric M. Meslin, Joe Kai and Nadeem Qureshi
J. Pers. Med. 2024, 14(4), 418; https://doi.org/10.3390/jpm14040418
Available online: https://www.mdpi.com/2075-4426/14/4/418
7. “BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report”
by Giulio Rossi, Luisella Righi, Francesca Barbisan, Marcello Tiseo, Paolo Spagnolo, Federica Grosso, Pasquale Pisapia, Umberto Malapelle, Marika Sculco, Irma Dianzani et al.
J. Pers. Med. 2024, 14(4), 394; https://doi.org/10.3390/jpm14040394
Available online: https://www.mdpi.com/2075-4426/14/4/394
8. “Autoimmunity in Syndromes of Orthostatic Intolerance: An Updated Review”
by Clarissa Pena, Abdelmoniem Moustafa, Abdel-Rhman Mohamed and Blair Grubb
J. Pers. Med. 2024, 14(4), 435; https://doi.org/10.3390/jpm14040435
Available online: https://www.mdpi.com/2075-4426/14/4/435
9. “Exploring the Gut Microbiome’s Role in Inflammatory Bowel Disease: Insights and Interventions”
by Despoina Gyriki, Christos Nikolaidis, Elisavet Stavropoulou, Ioanna Bezirtzoglou, Christina Tsigalou, Stergios Vradelis and Eugenia Bezirtzoglou
J. Pers. Med. 2024, 14(5), 507; https://doi.org/10.3390/jpm14050507
Available online: https://www.mdpi.com/2075-4426/14/5/507
10. “Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis”
by Rucsandra Cristina Dascălu, Andreea Lili Bărbulescu, Loredana Elena Stoica, Ștefan Cristian Dinescu, Cristina Elena Biță, Horațiu Valeriu Popoviciu, Răzvan Adrian Ionescu and Florentin Ananu Vreju
J. Pers. Med. 2024, 14(5), 535; https://doi.org/10.3390/jpm14050535
Available online: https://www.mdpi.com/2075-4426/14/5/535
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
26 November 2024
Journal of Personalized Medicine | Highly Cited Papers on Diabetes Health in 2022–2023

Discover the highly cited diabetes health research from 2022 to 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426). Recent advances in personalized medicine have opened new avenues for diabetes treatment, aiming to improve outcomes and quality of life for diabetes patients. Please feel free to read the selected articles below:
1. “Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care”
by Elpiniki Rentzeperi, Stavroula Pegiou, Theocharis Koufakis, Maria Grammatiki and Kalliopi Kotsa
J. Pers. Med. 2022, 12(3), 454; https://doi.org/10.3390/jpm12030454
Available online: https://www.mdpi.com/2075-4426/12/3/454
Citations: 46+ | Article Views: 8603+
2. “Predicting the Onset of Diabetes with Machine Learning Methods”
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406
Available online: https://www.mdpi.com/2075-4426/13/3/406
Citations: 42+ | Article Views: 7175+
3. “Multimorbidity, Frailty and Diabetes in Older People–Identifying Interrelationships and Outcomes”
by Alan J. Sinclair and Ahmed H. Abdelhafiz
J. Pers. Med. 2022, 12(11), 1911; https://doi.org/10.3390/jpm12111911
Available online: https://www.mdpi.com/2075-4426/12/11/1911
Citations: 18+ | Article Views: 3266+
4. “Anxiety, Distress and Stress among Patients with Diabetes during COVID-19 Pandemic: A Systematic Review and Meta-Analysis”
by Rubén A. García-Lara, José L. Gómez-Urquiza, María José Membrive-Jiménez, Almudena Velando-Soriano, Monserrat E. Granados-Bolivar, José L. Romero-Béjar and Nora Suleiman-Martos
J. Pers. Med. 2022, 12(9), 1412; https://doi.org/10.3390/jpm12091412
Available online: https://www.mdpi.com/2075-4426/12/9/1412
Citations: 15+ | Article Views: 3269+
5. “Precision Medicine for Hypertension Patients with Type 2 Diabetes via Reinforcement Learning”
by Sang Ho Oh, Su Jin Lee and Jongyoul Park
J. Pers. Med. 2022, 12(1), 87; https://doi.org/10.3390/jpm12010087
Available online: https://www.mdpi.com/2075-4426/12/1/87
Citations: 13+ | Article Views: 3420+
6. “Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach”
by Didier Ducloux and Cécile Courivaud
J. Pers. Med. 2022, 12(1), 116; https://doi.org/10.3390/jpm12010116
Available online: https://www.mdpi.com/2075-4426/12/1/116
Citations: 12+ | Article Views: 3381+
7. “Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?”
by Claire Deligne, Sylvaine You and Roberto Mallone
J. Pers. Med. 2022, 12(4), 542; https://doi.org/10.3390/jpm12040542
Available online: https://www.mdpi.com/2075-4426/12/4/542
Citations: 11+ | Article Views: 5836+
8. “Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes”
by Artemis Kyriakidou, Angeliki V. Kyriazou, Theocharis Koufakis, Yiannis Vasilopoulos, Maria Grammatiki, Xanthippi Tsekmekidou, Iakovos Avramidis, Stefanos Baltagiannis, Dimitrios G. Goulis, Pantelis Zebekakis et al.
J. Pers. Med. 2022, 12(3), 424; https://doi.org/10.3390/jpm12030424
Available online: https://www.mdpi.com/2075-4426/12/3/424
Citations: 11+ | Article Views: 4714+
9. “Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers”
by Miriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina Mejía-Abril et al.
J. Pers. Med. 2023, 13(3), 489; https://doi.org/10.3390/jpm13030489
Available online: https://www.mdpi.com/2075-4426/13/3/489
Citations: 9+ | Article Views: 2424+
10. “Menstrual Cycle, Glucose Control and Insulin Sensitivity in Type 1 Diabetes: A Systematic Review”
by Elena Gamarra and Pierpaolo Trimboli
J. Pers. Med. 2023, 13(2), 374; https://doi.org/10.3390/jpm13020374
Available online: https://www.mdpi.com/2075-4426/13/2/374
Citations: 5+ | Article Views: 2902+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
26 November 2024
Meet Us at the 2nd EFMC International Symposium on Chemical Biology, 29–31 January 2025, Basel, Switzerland

Conference: 2nd EFMC International Symposium on Chemical Biology (EFMC-ISCB)
Date: 29–31 January 2025
Location: Basel, Switzerland
We are pleased to announce that MDPI will participate in the 2nd EFMC International Symposium on Chemical Biology (EFMC-ISCB), held in Basel, Switzerland, from 29 to 31 January 2025.
The EFMC-ISCB conference, jointly organized by the European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the Swiss Chemical Society's Division for Medicinal Chemistry & Chemical Biology (DMCCB), will continue its tradition of high scientific quality and bring together leading scientists to showcase the latest advances in the field of chemical biology. The event will feature plenary and invited lectures, short communications, a poster session, and a commercial exhibition, providing ample opportunities for discussion and networking.
MDPI is excited to participate in this prestigious event. Adding to the excitement, the Editor-in-Chief of Drugs and Drug Candidates (ISSN: 2813-2998), Dr. Jean Jacques Vanden Eynde, and Editorial Board Member Dr. Annie Mayence will be attending the conference. They will be present at the MDPI exhibition stand where they warmly welcome all scholars to visit and engage in discussions. This event presents a unique opportunity for participants to interact with leading experts in the field and explore potential collaborations. Do not miss the chance to visit our stand and exchange ideas with DDC’s editors and other delegates.
The following MDPI journals will be represented at the conference:
- DDC;
- Pharmaceuticals;
- CIMB;
- Marine Drugs;
- Diseases;
- MPs;
- DNA;
- Biologics;
- JPM;
- LabMed.
If you are planning to attend the above conference, please do not hesitate to start a conversation with us. We invite all conference attendees to visit MDPI's booth and engage in meaningful conversations with our Editorial Board Members.
For more information about the conference, please visit the following website: https://www.efmc-iscb.org/.
15 November 2024
Prof. Dr. A. Douglas Kinghorn Appointed Chair of the 2024 Tu Youyou Award Committee

We are honored to announce that Prof. Dr. A. Douglas Kinghorn will serve as the Chair of the 2024 Tu Youyou Award Committee.
Name: Prof. Dr. A. Douglas Kinghorn
Affiliation: College of Pharmacy, The Ohio State University, USA
Prof. Dr. Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and edited or co-edited 40 scientific volumes.
The 2024 Tu Youyou Award Committee, under Prof. Dr. Kinghorn's guidance, will focus on identifying innovative research in the fields of natural products chemistry and medicinal chemistry. The committee will aim to identify groundbreaking work with the potential to lead to significant advancements in these areas.
We are confident that, with Prof. Dr. Kinghorn at the helm, the 2024 Tu Youyou Award will continue to inspire excellence and innovation in the related fields.
About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal.
The 2024 Tu Youyou Award remains open for nominations until 31 December 2024. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.
If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.
5 November 2024
MDPI INSIGHTS: The CEO's Letter #17 - OA Week, Basel Open Day, Beijing Graphene Forum

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week: Forging the Future of Open Access through Global Reach and Collaboration
From 21 to 27 October, we celebrated International Open Access Week (OAW), highlighting the importance of making research accessible to everyone. This campaign reinforced our commitment to advancing open access (OA) and showcased how we are helping research communities worldwide adopt OA as their standard.
“OA publishing is now a cornerstone of global research”
Throughout the week, we featured MDPI’s efforts to support quality open research through blog posts on topics such as how Research Integrity Promotes OA Practices, our Preprints.org platform, and supporting societies with different OA models. These initiatives capture our commitment to making research more inclusive and accessible to all.
OA publishing is now a cornerstone of global research, with more researchers choosing OA over traditional paywalled models, and embracing new, community-driven models.
Benefits of Open Access and Open Research
- Accelerated Discoveries: OA speeds up scientific progress by allowing immediate access to findings, enabling researchers to build on each other’s work faster.
- Community-Led Innovation: Open research empowers communities to manage their own platforms, creating collaboration and shared knowledge.
- Increased Visibility: OA broadens the reach of your research, leading to greater recognition, collaboration, and impact.
- Cross-Disciplinary Connections: By removing financial and geographical barriers, OA unites diverse fields, sparking innovation across disciplines.
MDPI Singapore Celebrates Open Access Week
MDPI Singapore also hosted its first-ever OAW event at the Marina Bay Sands Convention Centre, bringing together academics, researchers, and students to discuss the future of open scholarship. Conversations focused on the potential of new publishing models, alternative funding strategies, and the importance of communicating research to wider audiences.
As OA evolves, MDPI remains a committed partner in advancing open science and creating a transparent, inclusive research environment. For a full recap of the week’s highlights and resources, visit our campaign page.
Impactful Research
MDPI Connection to Nobel-Winning Protein Research
David Baker, an American biochemist, and Demis Hassabis and John M. Jumper, two scientists from Google DeepMind, have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking advancements in better understanding the structure of proteins, the molecular engines of life’s processes.
One half of the prize was awarded to Professor David Baker from the University of Washington for his development of revolutionary protein design software enabling the creation of novel proteins for vaccines, nanomaterials, and sensors. Prof. Baker co-authored a 2016 paper in MDPI’s Toxins journal on protein-based therapeutics.
Meanwhile, DeepMind’s Demis Hassabis and John M. Jumper received recognition for AlphaFold, the AI model that predicts protein structures from amino acid sequences, fulfilling a long-held scientific dream.
“We congratulate this year’s Nobel laureates for their groundbreaking contributions to the study of life”
Nobel Prize Laureates Entrust MDPI with Their Research
As at October 2024, 45 Nobel laureates had contributed to more than 115 articles across
35 MDPI journals. The privilege of hosting the research of such contributors, who significantly influence the open access movement, resonates deeply with our editorial teams.
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath, Tomas Lindahl, Thomas C. Südhof, Stanley B. Prusiner, Roger Kornberg, Robert F. Engle, Richard J. Roberts, Ōmura Satoshi, Kenneth J. Arrow, John B. Goodenough, Jennifer Doudna, Hamilton Othanel Smith, Eric R. Kandel, Carlo Rubbia, Bernard Feringa, Barry J. Marshall, Anthony J. Leggett, Andrew Victor Schally, and David Baker.
Notable MRNA Published in Cells
On 7 October 2024, the 2024 Nobel Prize in Physiology or Medicine was jointly awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
MicroRNAs are proving to be fundamentally important for how organisms develop and function. Some interesting papers about microRNA research are published in the MDPI journal Cells. I invite you browse through the notable papers related to microRNA research in Cells.
Inside MDPI
Basel Open Day
On 21 October, we held the Basel Open Day at our headquarters, welcoming a group of journal Editors-in-Chief (EiC) and Editorial Board Members (EBMs) for a full-day workshop. The event featured presentations and discussions on MDPI’s latest editorial updates, data integrity policies, society collaborations, and local market insights.
The following MDPI journals were represented during the visit: Physics, Journal of Personalized Medicine (JPM), Sci, Remote Sensing, Animals, Cells, Buildings, Histories, Sensors, and International Journal of Environmental Research and Public Health (IJERPH).
This was a great opportunity to showcase our new office space while gathering feedback from leading journal stakeholders. To get everyone on the same page, we took 60 minutes for round-table introductions, which helped set a collaborative tone and ground us in MDPI’s mission of disseminating open science.
“This was a great opportunity to gather feedback from leading journal stakeholders”
The general feedback from the day highlighted positive developments around our editorial and ethics policies, as well as areas for improvement, including flexibility regarding reviewer deadlines. There was a genuine appreciation and push for our ongoing efforts to share more about MDPI, including company updates and promoting high-quality research through our blog, announcements, and social media channels, which we have been growing and expanding.
Our Basel Open Day was a positive experience, bringing together key journal stakeholders and gathering insights to guide MDPI’s continued engagement with the academic community. We look forward to hosting future events of this kind and welcoming more scholars to our headquarters in Basel, Switzerland.
Coming Together for Science
ncRNA 2024 Conference in Basel
I am pleased to share that we held Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ICM 2024) in Basel, Switzerland this past 7–9 October.
The three-day event attracted just over 100 attendees, including two Chairs, 10 invited speakers and two keynotes from Prof. Mauro Giacca and Prof. Ling-Ling Chen. Of the presentations on site, there were 35 posters and 44 oral presentations.
The overall feedback was positive, with people enjoying the intimate event and the unique activities offered, including a guided tour around Basel’s Old Town (a must-see for anyone visiting the city) and a memorable conference dinner.
It was cool to see the winners of the 2024 Nobel Prize in Physiology or Medicine announced during the conference days. This was exciting for attendees, as the winners discovered a new class of RNA molecules (miRNAs). As one invited speaker put it, “It's exciting to be among fellows when something that important for the field is announced.”
“It's exciting to be among fellows when something that important for the field is announced”
Every attendee receives a conference survey, and I’m always pleased to see a high percentage of ‘Very Satisfied’ responses when asked about ‘treatment from conference personnel’. Kudos to our conference team for meeting our attendees’ needs. These events are a great opportunity for us to reach new audiences, as 92% of the respondents had never been to an MDPI conference, so I am thrilled to see us connecting with a new demographic of your researchers in the RNA field.
A special thank-you to our partnering societies The Epigenetics Society, The French Society of Genetics, LS2 / USGEB (Union of Swiss Societies for Experimental Biology), and The RNA Biology Group, as well as to our sponsors New England Biolabs and Arraystar for their support of the ncRNA 2024 conference. I am also pleased to report that we presented two awards, including the Best Presentation Award and two Best Poster Award, recognizing the contributions of our participants.
Upcoming In-Person Event
27–29 November 2024
Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life
Location: Barcelona, Spain
The discovery of new molecules, their properties, and actions to enhance human health and quality of life.
Find more upcoming MDPI events here.
Closing Thoughts
Beijing Graphene Forum 2024
I am pleased to share that we had a successful time at the Beijing Graphene Forum 2024, which drew around 1,000 attendees, including Konstantin Novoselov (2015 Nobel Prize in Physics) and other high-profile scholars in materials science and chemistry. It was a great opportunity to present MDPI on the big stage, with university presidents from institutions such as Peking University also in attendance.
I had the honour of awarding Prof. Zhongfan Liu, Chairman of the Chemical Science Committee, with a medal and presenting certificates to the members of the Chemical Science Committee; this is an important initiative to help expand MDPI’s journals and influence in China. These are highly respected scholars, and we enjoyed connecting with them over lunch as well.
“This is an important initiative to help expand MDPI’s journals and influence in China”
I also had the chance to speak about MDPI and open access, giving a five-minute speech during the opening ceremony and a 20-minute presentation at the close. MDPI hosted a sub-forum where both academic scholars and MDPI members shared insights, and we engaged with attendees at our MDPI booth.
This was a great opportunity to spotlight MDPI as the main publishing partner for the event, and I was proud to represent us on stage. We also met with scholars to discuss topics such as their publishing needs and institutional policies, open access, impact journals, and IOAP.
Chief Executive Officer
MDPI AG
28 October 2024
Meet Us at Pharmacology 2024, 10–12 December 2024, Harrogate, UK

Conference: Pharmacology 2024
Date: 10–12 December 2024
Location: Harrogate, UK
MDPI will be attending Pharmacology 2024 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.
The British Pharmacological Society is a charity and global membership community whose mission is to promote and advance the whole spectrum of pharmacology. It leads the way in pharmacology research and application around the world, with around 4,000 members from more than 60 countries. Each year, the British Pharmacological Society hosts its annual Pharmacology conference, gathering individuals from academia, healthcare, industry, and the regulatory sector to share and celebrate the latest research and developments in this field and other related areas. This conference is a great opportunity for those studying and working in this field to attend lectures from experts and emerging researchers, network, socialize, and showcase their own work.
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.miceconciergeme.com/pharmacology-2024.
The following MDPI journals will be represented:
- Pharmaceuticals;
- Pharmacoepidemiology;
- Pharmacy;
- Antioxidants;
- Neurology International;
- Future Pharmacology;
- BioTech;
- Cancers;
- Sci. Pharm.;
- Sclerosis;
- Medicines;
- JPM;
- DDC.
The year 2024 marks the 20th anniversary of Pharmaceuticals (ISSN: 1424-8247), a peer-reviewed open access journal on medicinal chemistry and related drug sciences, published monthly online by MDPI. With an Impact Factor of 4.3 and a CiteScore of 6.1, the journal is covered in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder, and other databases. The journal has published more than 6000 papers from more than 37,000 authors. More than 10,000 reviewers have reviewed the journal at least once. We value the contributions made by our editors, authors, and reviewers.
28 October 2024
Journal of Personalized Medicine | Selected Popular Special Issues in 2023–2024

Explore the 2023–2024 popular Special Issues from the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), encompassing advanced topics in surgery, genomics, and personalized prevention and treatment strategies. We warmly invite scholars to delve into these issues and contribute to the ongoing dialogue in personalized medicine.
![]() |
![]() |
“Computer Assisted Maxillo-Facial Surgery” Guest Editors: Dr. Giovanni Gerbino and Dr. Emanuele Zavattero Cited by 41+ | Viewed by 29500+ |
“Precision Medicine Genomics: Pharmacogenomics” Guest Editors: Dr. Luis Andrés López-Fernández, Dr. Sara Salvador-Martín and Dr. Matea Zajc Petranović Cited by 28+ | Viewed by 20300+ |
![]() |
![]() |
“Personalized Medicine for Coronary Artery Disease: Diagnosis, Prevention, and Treatment” Guest Editor: Dr. Jacek Bil Cited by 27+ | Viewed by 17900+ |
“Innovations in Knee and Hip Arthroplasty” Guest Editor: Prof. Dr. Günther Maderbacher Cited by 12+ | Viewed by 14300+ |
You are welcome to view all the Special Issues, submit relevant papers to Journal of Personalized Medicine, and subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
28 October 2024
Journal of Personalized Medicine | Highly Cited Papers on Oral Health in 2022–2023

Discover the highly cited oral health research from 2022–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426). Explore groundbreaking studies and insights that are shaping personalized dental care. Please feel free to read the selected articles below.
1. “Dental and Skeletal Side Effects of Oral Appliances Used for the Treatment of Obstructive Sleep Apnea and Snoring in Adult Patients—A Systematic Review and Meta-Analysis”
by Ioannis A. Tsolakis, Juan Martin Palomo, Stefanos Matthaios and Apostolos I. Tsolakis
J. Pers. Med. 2022, 12(3), 483; https://doi.org/10.3390/jpm12030483
Available online: https://www.mdpi.com/2075-4426/12/3/483
Cited by 16+ | Viewed by 4870+
2. “Effectiveness of Virtual Reality-Based Training on Oral Healthcare for Disabled Elderly Persons: A Randomized Controlled Trial”
by Ai-Hua Chang, Pei-Chen Lin, Pei-Chao Lin, Yi-Ching Lin, Yuji Kabasawa, Cheng-Yu Lin and Hsiao-Ling Huang
J. Pers. Med. 2022, 12(2), 218; https://doi.org/10.3390/jpm12020218
Available online: https://www.mdpi.com/2075-4426/12/2/218
Cited by 16+ | Viewed by 3680+
3. “The Predictive Value of Systemic Immune-Inflammation Index and Symptom Severity Score for Sepsis and Systemic Inflammatory Response Syndrome in Odontogenic Infections”
by Marius Pricop, Oana Ancusa, Serban Talpos, Horatiu Urechescu and Bogdan Andrei Bumbu
J. Pers. Med. 2022, 12(12), 2026; https://doi.org/10.3390/jpm12122026
Available online: https://www.mdpi.com/2075-4426/12/12/2026
Cited by 16+ | Viewed by 2110+
4. “Three-Dimensional Accuracy and Stability of Personalized Implants in Orthognathic Surgery: A Systematic Review and a Meta-Analysis”
by Alexandru Diaconu, Michael Boelstoft Holte, Gabriele Berg-Beckhoff and Else Marie Pinholt
J. Pers. Med. 2023, 13(1), 125; https://doi.org/10.3390/jpm13010125
Available online: https://www.mdpi.com/2075-4426/13/1/125
Cited by 12+ | Viewed by 2950+
5. “Blood Cell Count Inflammatory Markers as Prognostic Indicators of Periodontitis: A Systematic Review and Meta-Analysis”
by Oana Almășan, Daniel-Corneliu Leucuța and Mihaela Hedeșiu
J. Pers. Med. 2022, 12(6), 992; https://doi.org/10.3390/jpm12060992
Available online: https://www.mdpi.com/2075-4426/12/6/992
Cited by 10+ | Viewed by 1600+
6. “A New Detection Method of Oral and Oropharyngeal Squamous Cell Carcinoma Based on Multivariate Analysis of Surface Enhanced Raman Spectra of Salivary Exosomes”
by Cosmin Ioan Faur, Cristian Dinu, Valentin Toma, Anca Jurj, Radu Mărginean, Anca Onaciu, Rareș Călin Roman, Carina Culic, Magdalena Chirilă, Horațiu Rotar et al.
J. Pers. Med. 2023, 13(5), 762; https://doi.org/10.3390/jpm13050762
Available online: https://www.mdpi.com/2075-4426/13/5/762
Cited by 9+ | Viewed by 2280+
7. “Three-Dimensional Guided Zygomatic Implant Placement after Maxillectomy”
by Nathalie Vosselman, Haye H. Glas, Bram J. Merema, Joep Kraeima, Harry Reintsema, Gerry M. Raghoebar, Max J. H. Witjes and Sebastiaan A. H. J. de Visscher
J. Pers. Med. 2022, 12(4), 588; https://doi.org/10.3390/jpm12040588
Available online: https://www.mdpi.com/2075-4426/12/4/588
Cited by 9+ | Viewed by 2970+
8. “Simultaneous PSI-Based Orthognathic and PEEK Bone Augmentation Surgery Leads to Improved Symmetric Facial Appearance in Craniofacial Malformations”
by Valentin Kerkfeld, Lara Schorn, Rita Depprich, Julian Lommen, Max Wilkat, Norbert Kübler, Majeed Rana and Ulrich Meyer
J. Pers. Med. 2022, 12(10), 1653; https://doi.org/10.3390/jpm12101653
Available online: https://www.mdpi.com/2075-4426/12/10/1653
Cited by 8+ | Viewed by 2430+
9. “Association between Periodontitis Extent, Severity, and Progression Rate with Systemic Diseases and Smoking: A Retrospective Study”
by Georgios S. Chatzopoulos, Ziou Jiang, Nicholas Marka and Larry F. Wolff
J. Pers. Med. 2023, 13(5), 814; https://doi.org/10.3390/jpm13050814
Available online: https://www.mdpi.com/2075-4426/13/5/814
Cited by 7+ | Viewed by 2350+
10. “Radiation Exposure and Frequency of Dental, Bitewing and Occlusal Radiographs in Children and Adolescents”
by Ina Manuela Schüler, Christoph-Ludwig Hennig, Rika Buschek, Rebecca Scherbaum, Collin Jacobs, Marcel Scheithauer and Hans-Joachim Mentzel
J. Pers. Med. 2023, 13(4), 692; https://doi.org/10.3390/jpm13040692
Available online: https://www.mdpi.com/2075-4426/13/4/692
Cited by 6+ | Viewed by 4830+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
16 October 2024
MDPI's Newly Launched Journals in September 2024
Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.
We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.
We invite you to explore and learn more about these new journals below.
Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
![]() |
Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA | Editorial | view inaugural issue | biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies | view journal scope | submit an article |
![]() |
Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece | Editorial | view inaugural issue | surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article |
![]() |
Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA | Editorial | view inaugural issue | ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves | view journal scope | submit an article |
![]() |
Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain | Editorial | view inaugural issue | hospital management; hospital facilities; hospital services; hospital risk management; health law | view journal scope | submit an article |
![]() |
Prof. Dr. Nicola Ferri, University of Padova, Italy | Editorial | view inaugural issue | lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.
4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Joins the Science Summit at UNGA79 (23–27 September 2024, New York)
On Friday 27 September, I had the privilege of giving the opening talk at the “Youth at the Science Summit” panel during the Science Summit conference, held in New York at the 79th session of the United Nations General Assembly (UNGA). Together, we discussed the future of science, publishing, innovation, and sustainable development.
It was a great opportunity to learn from our young leaders, whose voices must be included in the conversation as science shapes the future of artificial intelligence, climate mitigation, healthcare, technology, and more. This was also a powerful reminder of how essential global collaboration is in solving the major challenges we face. I left inspired by the dedication of these young researchers to making the world a better place!
Today’s youth are not just the leaders of tomorrow – they are already leading the change today.
Stefan Tochev (second from left) at the UNGA Science Summit 2024: “A great opportunity to learn from our young leaders.”
MDPI Supports the Future Generation of Scientists
This aligns with MDPI’s mission to support the next generation of scientists and early-career researchers by recognizing their achievements through our various MDPI awards, including the Young Investigator Awards, Best PhD Thesis Awards, Travel Awards, and more.
Our presence at this global event showed our commitment to advancing Open Science as a key driver for sustainable development. As a leading Open Access (OA) publisher, MDPI’s role at the summit was to emphasize the critical importance of democratizing scientific knowledge, making it accessible to all, and promoting global collaboration.
Through OA publishing, we aim to address pressing global challenges such as climate change, public health, and inequality, in line with the United Nations Sustainable Development Goals (SDGs).
“We aim to address pressing global challenges”
MDPI and the SDGs
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs.
During the summit, we highlighted the connection between Open Science and the SDG Publishers Compact, supporting the core objective to “Leave No One Behind” (LNOB). The transformative promise of the SDGs relies heavily on the Open Access model, which serves as a fundamental enabler of Open Science. We advocate for the wider adoption of Open Science practices in order to achieve the SDGs by 2030.
Impactful Research
Presenting at the 1st International Conference of Environmental Medicine
In September, MDPI and our journals IJERPH and Diseases sponsored and participated in the 1st International Conference of Environmental Medicine: Environmental Threats to Human Health: From Genetics to Epigenetics, held in Chieti, Italy.
The conference was organized in collaboration with various societies, including the Italian Society of Environmental Medicine (SIMA), one of more than 160 societies partnering MDPI journals.
The conference brought together influential figures from the Italian scholarly community, such as Antonio Felice Uricchio (President of the National Agency for University Research Assessment [ANVUR]), Alessandro Miani (President of SIMA), and Liborio Stuppia (Director of ‘Gabriele d’Annunzio’ University of Chieti-Pescara), among others.
MDPI was the sole publishing sponsor of the conference, at which I had the opportunity to present on behalf of the company. I provided an overview of MDPI, covering key facts and figures, the peer-review process, our strong collaboration with the Italian market, and insights into Nobel Prize winners who have published with MDPI, ahead of Sir Richard Roberts’ Nobel lecture.
“As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals”
The keynote speaker at the event was Sir Richard Roberts, Nobel Laureate and 1993 Nobel Prize winner in Medicine, recognized for his discovery of split genes.
Nobel Laureates’ Contributions to MDPI
As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals. I’ll share more details on this in the October newsletter.
Hosting such prominent figures in their respective fields, who play a significant role in advancing the OA movement, of which we are leaders in, resonates deeply with our editorial teams.
Sponsoring and supporting academic conferences is something we do on a large scale, and it continues to grow. Attending and speaking about MDPI shows our commitment by taking the time to connect with the scholarly community in person.
MDPI’s Presence in Italy
Italy ranks third globally in total MDPI publications, with nearly 130,000 contributions. We collaborate with about 12,000 Editorial Board Members in Italy, over 6,100 of whom have an H-index of more than 25.
We have 83 Editors-in-Chief and 209 Section Editors-in-Chief from Italy. We also support 20 Italian universities through our Institutional Open Access Program (IOAP) agreements with major institutions such as Sapienza University of Rome, the University of Milan, and the University of Pisa, among others.
Inside MDPI
Celebrating Peer Review Week, 23–27 September 2024
As we conclude another productive month at MDPI, I am pleased to highlight our participation in this year’s Peer Review Week (PRW), which took place from 23–27 September 2024. This global, community-driven celebration underscores the vital importance of peer review in maintaining the integrity and reliability of academic work. PRW provide a platform for institutions, publishers, and scholars to come together and reflect on the processes that uphold the quality of scholarly communication.
“We remain committed to enhancing the peer review process”
The theme for PRW 2024 was ‘Innovation and Technology in Peer Review.’ At MDPI, we were proud to contribute through various online and in-person events, including webinars from Europe, Asia-Pacific, and a roundtable discussion on innovation and technology in peer review. These events offer an opportunity to explore new tools and technologies that are shaping the future of peer review, particularly the integration of AI. As a company, we remain committed to enhancing the peer review process with innovative solutions while preserving the essential human expertise that makes it effective.
Peer Review Innovation and Technology at MDPI
Our efforts to improve peer review extend beyond the activities of this week. We also released a blog article discussing New Tools for Advancing Research Integrity and Peer Review, where we highlight two tools that MDPI has developed to support research integrity: Eureka – Reviewer Recommender and Online Proofreader. We are continually refining SuSy, our in-house submission system, to provide a seamless experience for authors and reviewers alike.
Listening to MDPI’s Authors and Reviewers
We highly value the time of our reviewers, and so do the authors who contribute to our journals. Our editorial process is bolstered by a network of dedicated reviewers, a team of over 6,000 diligent, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes.
We make it a point to continually improve the experiences of both our authors and our reviewers throughout the entire editorial process, from submission to publication. This is why we regularly ask for feedback by conducting surveys. Here is what some of our respondents recently had to say about working with MDPI:
Coming Together for Science
ICM 2024 – Advances in Material Innovation
I am pleased to share that we held The 5th International Conference on Materials: Advances in Material Innovation (ICM 2024) in Basel, Switzerland this past 25–27 September.
This intimate event brought together leading scientists, researchers, and industry experts to exchange insights on recent advancements in materials characterization, processing, and manufacturing. Key focus areas included nanotechnology in material sciences and engineering, optical, electrical, and magnetic materials, soft, biological, and biomaterials, fibres, membranes, thin films, sensing materials, as well as materials and devices for energy and solar fuels. In addition, discussions featured the integration of AI and machine learning in materials research.
We received 90 abstract submissions. Over the course of the three-day event, 18 posters were displayed, and 34 talks were delivered, including three plenary speeches, seven invited talks, and 24 selected oral presentations.
A special thank-you to our partnering societies The Polish Membrane Society and The North American Thermal Analysis Society, as well as our sponsor, Nanomegas, for their support of the ICM conference. I am also pleased to share that we presented three awards, including the Best Presentation Award and two Best Poster Awards, recognizing the outstanding contributions of our participants.
Upcoming In-Person Event
7–9 October 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland
ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.
Find more upcoming MDPI events here.
Closing Thoughts
Reflections from OASPA 2024 Conference in Lisbon (16–18 September)
Amidst my September travels, I also had pleasure of attending the OASPA 2024 Conference in Lisbon from 16–18 September. It’s the first in-person Open Access Scholarly Publishing Association (OASPA) event in five years, and being in the sunny city of Lisbon made it even better! MDPI has long been a member of OASPA, and attending this conference gave us an opportunity to connect with other key members of the organization to see the latest developments in the OA movement.
“I believe that publishers have a lot to offer in terms of data and insights”
Main Themes from OASPA 2024
The main themes covered were equity and inclusivity, diamond OA, AI and openness, OA books, research integrity, and how OA can address broader societal challenges such as climate change. While it was great to see the latest developments in these areas, it was also clear that certain voices were missing, particularly those of major publishers. Although it’s not easy to incorporate every perspective, I believe that publishers, including MDPI, have a lot to offer in terms of data and insights. During the membership meeting, a few of us raised the point that large-scale publisher input could add value to these discussions.
It’s important to participate in industry conferences such as OASPA in order to be part of the discussions and remain at the forefront of the OA movement.
It’s an opportunity to build meaningful relationships with organizations that share our commitment to OA.
While sponsorship is one way to show our support, it’s clear that being part of the conversation through participating in the OASPA groups and committee is what really makes a difference.
It took the last 20 years for more than 50% of the world's research to be published via open access. This provides a sobering reminder that flipping the remaining 50% will be a big challenge.
An important takeaway for me was that there is no "one-size-fits-all" solution for OA challenges: different regions and different stakeholders need different forms of support, whether it is infrastructure, funding, education, or policy, for example. I also enjoyed Rebecca Ross' presentation on how OA can drive action on climate. A few panellists shared the need for transparency in the peer-review process, advocating for open review reports, which is something we have been offering since 2014.
Speaking of openness, we are excited to celebrate Open Access Week 2024 with the scholarly community from 21–27 October. I look forward to sharing a recap of our activities in the next newsletter.
Chief Executive Officer
MDPI AG